Raclopride
- Generic Name
- Raclopride
- Drug Type
- Small Molecule
- Chemical Formula
- C15H20Cl2N2O3
- CAS Number
- 84225-95-6
- Unique Ingredient Identifier
- 430K3SOZ7G
- Background
Raclopride has been used in trials studying Parkinson Disease.
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
Phase 4
Recruiting
- Conditions
- PsychosisAnhedoniaDepression
- Interventions
- Drug: Matching Placebo Patch
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 103
- Registration Number
- NCT05282277
- Locations
- 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia
Withdrawn
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2020-05-29
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT03999190
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
Brain Dopamine Function in Human Obesity
Early Phase 1
Completed
- Conditions
- Healthy VolunteersObesityOverweight
- Interventions
- Drug: [18F]fallypride
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2023-07-11
- Target Recruit Count
- 61
- Registration Number
- NCT03648892
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's Disease
Completed
- Conditions
- Parkinson DiseaseHealthy
- First Posted Date
- 2002-04-03
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 64
- Registration Number
- NCT00032812
- Locations
- 🇺🇸
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath